Hypoxia and hypoxemia are two different entities. Correcting hypoxemia without hypoxia tends to have disastrous effects and delays lung healing. In this study, we share a case of an elderly man with moderate COVID-19 who never received any form of supplemental oxygen as compared to other patients with similar presentation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710785PMC
http://dx.doi.org/10.1002/ccr3.5254DOI Listing

Publication Analysis

Top Keywords

oxygen friend
4
friend foe
4
foe covid-19
4
covid-19 battle
4
battle hypoxia
4
hypoxia hypoxemia
4
hypoxemia entities
4
entities correcting
4
correcting hypoxemia
4
hypoxemia hypoxia
4

Similar Publications

Background: In organ transplantation, cold ischemia is associated with sterile inflammation that subsequently conditions adaptive immunity directed against the grafts during revascularization. This inflammation is responsible for venous thrombosis, which is the main postoperative complication affecting graft function. Our aim was to investigate the modulation of immune responses and endothelial function of pancreatic grafts during cold ischemia using different preservation modalities.

View Article and Find Full Text PDF

Background: The clinical standard for pancreas preservation for transplantation is static cold storage (SCS). Oxygenation during preservation has been shown to be advantageous in clinical studies. This study evaluates the efficiency of different oxygenation modalities during hypothermic pancreas preservation.

View Article and Find Full Text PDF

Interstitial lung diseases (ILDs) have an impact on patient quality of life at some point. Alternatives such as pulmonary rehabilitation, oxygen supplementation, yoga, and mindfulness practices can help in the care of patients with ILD. The current study was designed to explore the perceptions of gratitude by patients with various ILDs during an MBI.

View Article and Find Full Text PDF

Ozone and procaine in knee osteoarthritis. Friend or foe?

Int Immunopharmacol

December 2024

Italian Scientific Society of Oxygen-Ozone Therapy (SIOOT) and High Master School of Oxygen-Ozone Therapy, University of Pavia, Italy.

View Article and Find Full Text PDF

Recent Progress of Antisense Oligonucleotide Therapy for -Mutated Amyotrophic Lateral Sclerosis: Focus on Tofersen.

Genes (Basel)

October 2024

Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Amyotrophic lateral sclerosis (ALS) is a refractory neurodegenerative disease characterized by the degeneration and loss of motor neurons, typically resulting in death within five years of onset. There have been few effective treatments, making the development of robust therapies an urgent challenge. Genetic mutations have been identified as contributors to ALS, with mutations in (), which neutralizes the harmful reactive oxygen species superoxide, accounting for approximately 2% of all ALS cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!